A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/404 (2006.01) A61K 31/437 (2006.01) A61K 31/4523 (2006.01) A61K 31/454 (2006.01) A61K 31/496 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2609783
Combination therapies for treating obesity or related eating disorders and/or reducing food consumption are described herein which comprises administering a therapeutically effective amount of a cannabinoid-1 (CB-1) receptor antagonist and an intestinal-acting microsomal triglyceride transfer protein inhibitor (MTPi) to an animal in need of such treatment. The CB-1 receptor antagonist and intestinal-acting MTPi may be administered separately or together.
L'invention concerne des polythérapies destinées à traiter l'obésité ou des troubles de l'alimentation associés et/ou à réduire la consommation alimentaire, et consistant à administrer une dose thérapeutiquement efficace d'un antagoniste du récepteur cannabinoïde 1 (CB-1) et d'un inhibiteur de la protéine microsomale de transfert des triglycérides (MTPi) à action intestinale à un animal nécessitant un tel traitement. L'antagoniste du récepteur CB-1 et le MTPi à action intestinale peuvent être administrés séparément ou ensemble.
Patterson Terrell Ann
Swick Andrew Gordon
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Combination of a cannabinoid-1- receptor-antagonist and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of a cannabinoid-1- receptor-antagonist and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a cannabinoid-1- receptor-antagonist and a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1532844